⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.
Broad-Spectrum Antioxidants
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-10-10 — Antioxidant Therapy, N-acetyl-L-cysteine, Effects on Pancreatic Beta Cells: Therapeutic Promise or Potential Harm?: cross-connection with n-acetylcysteine: NAC joins the broader pattern that antioxidant supplementation can backfire via reductive stress when baseline oxidative tone is physiological rather than pathological. (novelty: 3)
- 2026-09-15 — Antioxidant Interventions on Muscle Function and Mass in Aging-Related Muscle Decline: A Systematic Review of Preclinical and Clinical Evidence.: cross-connection with antioxidant-interventions: Systematic review reinforces a recurring pattern across antioxidant classes: strength/power endpoints move more reliably than muscle mass or physical performance in aging populations. (novelty: 3)
- 2026-08-12 — The Mito-Frail Trial: Effects of MitoQ on Vasodilation, Mobility and Cognitive Performance in Frail Older Adults: cross-connection with mitoq: Mito-Frail extends the broader antioxidant-for-aging hypothesis by testing a compartment-targeted variant against hard functional endpoints in frailty rather than systemic ROS scavengers. (novelty: 3)
Open questions
Related
Contributing findings
The complex relationship between oxidative stress and aging: new perspectives on similarities and differences.
16-apr-2026
novelty 2
per-area 2
weakens